Compare CNDT & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNDT | PROF |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Canada |
| Employees | 51000 | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 230.4M |
| IPO Year | 2016 | 2017 |
| Metric | CNDT | PROF |
|---|---|---|
| Price | $1.59 | $6.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.6M | 162.0K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | ★ $3,042,000,000.00 | $10,680,000.00 |
| Revenue This Year | $4.90 | $61.09 |
| Revenue Next Year | $3.10 | $120.94 |
| P/E Ratio | ★ N/A | $6.10 |
| Revenue Growth | N/A | ★ 48.35 |
| 52 Week Low | $1.18 | $3.90 |
| 52 Week High | $3.79 | $8.95 |
| Indicator | CNDT | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 43.60 | 49.06 |
| Support Level | $1.18 | $6.00 |
| Resistance Level | $1.55 | $7.11 |
| Average True Range (ATR) | 0.14 | 0.51 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 71.43 | 50.74 |
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.